Literature DB >> 11348890

Preeclampsia and fetal loss in women with a history of venous thromboembolism.

I Pabinger1, H Grafenhofer, A Kaider, A Ilic, S Eichinger, P Quehenberger, P Husslein, C Mannhalter, K Lechner.   

Abstract

A higher prevalence of risk factors for venous thromboembolism (VTE) has been found in women with preeclampsia and fetal loss. We investigated whether women with a history of VTE have a higher prevalence of pregnancy-associated complications compared with control subjects. In 395 patients with a history of VTE and in 313 control women, the prevalence of complications during pregnancy and the mean birth weight of viable infants were evaluated. The prevalence of pregnancy-induced hypertension and preeclampsia was higher in patients (5.1% and 3.0%, respectively) compared with control subjects (1.3% each). The odds ratio was 4.13 for pregnancy-induced hypertension (95% CI 1.4 to 12.22, P=0.0058) and 2.43 for preeclampsia (95% CI 0.78 to 7.6, P=0.133). Stillbirth was slightly more frequent in patients (4.3%) than in control subjects (3.2%); the difference was not statistically significant. Miscarriage was equally frequent in patients (21.8%) and control subjects (21.3%). The birth weight of viable infants born to patients was, on average, 109 g lower than that of the infants born to the control subjects (P=0.014) after adjustment for the mother's body mass index. Our study demonstrates that women with a predisposition to VTE have, overall, a good chance for a successful pregnancy outcome. However, the findings from our study support the assumption that a predisposition to venous thrombosis is associated with a higher risk for complications during pregnancy and lower infant birth weight.

Entities:  

Mesh:

Year:  2001        PMID: 11348890     DOI: 10.1161/01.atv.21.5.874

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  6 in total

1.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

2.  Thrombophilia and damage of kidney during pregnancy.

Authors:  Larciprete Giovanni; Liumbruno Giancarlo Maria; Rongioletti Mauro; Montagnoli Carlotta; Rossi Federica; Papa Fabrizio; Jarvis Sheba; Di Pierro Giuseppe; Bompiani Alessandro; Cirese Elio; Valensise Herbert
Journal:  J Prenat Med       Date:  2011-10

Review 3.  Preeclampsia, hypoxia, thrombosis, and inflammation.

Authors:  Amir A Shamshirsaz; Michael Paidas; Graciela Krikun
Journal:  J Pregnancy       Date:  2011-12-11

4.  Oxidative status of maternal blood in pregnancies burdened by inherited thrombophilias.

Authors:  Jelena Bogdanović Pristov; Miloš Opačić; Milica Bajčetić; Vesna Mandić; Dragana Maglić; Željko Miković; Ivan Spasojević
Journal:  PLoS One       Date:  2020-06-17       Impact factor: 3.240

5.  Clinical Significance of Detection of Coagulation Indexes, Immune Factors and Inflammatory Factors in Patients with Pregnancy-Induced Hypertension Syndrome in China.

Authors:  Fengmei Shi; Aijun Yu; Limei Yuan
Journal:  Iran J Public Health       Date:  2019-04       Impact factor: 1.429

Review 6.  Human Chorionic Gonadotrophin: New Pleiotropic Functions for an "Old" Hormone During Pregnancy.

Authors:  Virginie Gridelet; Sophie Perrier d'Hauterive; Barbara Polese; Jean-Michel Foidart; Michelle Nisolle; Vincent Geenen
Journal:  Front Immunol       Date:  2020-03-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.